收藏切换
Rapid health technology assessment of palonosetron in the prevention of chemotherapy-induced nausea and vomiting
收藏切换
Yue YOU, Xiaoju XU, Guorong FAN*
World Clinical Drug | 2023, 44(6) : 580 - 586
Less
收藏切换
World Clinical Drug | 2023, 44(6): 580-586
• Article •
Rapid health technology assessment of palonosetron in the prevention of chemotherapy-induced nausea and vomiting
Full
Yue YOU, Xiaoju XU, Guorong FAN*
Affiliations
  • Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
Published: 2023-06-10 doi: 10.13683/j.wph.2023.06.011
Outline
收藏切换
Objective

To rapidly evaluate the efficacy, safety and economy of palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV), so as to provide evidence-based support for clinical drug use.

Methods

By retrieving several major Chinese and English database, HTA reports, systematic reviews/meta-analysis and pharmacoeconomic studies about palonosetron in the prevention of CINV were included. The quality evaluation and summary analysis of the included literature were performed.

Results

A total of 17 literatures were included, involving 7 systematic reviews/meta-analysis and 10 pharmacoeconomic studies. In terms of effectiveness, palonosetron had obvious advantages in the complete control rate of CINV in acute phases, delay phases and overall phases compared with the first generation 5-hydroxytryptamine 3 receptor antagonist (5-HT3RA). In terms of safety, there was no statistical significance in the incidence of common adverse reaction between palonosetron and other 5-HT3RA (P>0.05). Pharmacoeconomic studies showed that the efficacy of palonosetron was higher than other 5-HT3RA, but the cost was higher as well. It was necessary to compare the threshold of willingness to pay to determine its economy.

Conclusion

Palonosetron has good efficacy and safety in preventing CINV, but the economy needs to be further verified.

palonosetron  /  chemotherapy-induced nausea and vomiting  /  rapid health technology assessment  /  efficacy  /  safety  /  economy
尤越, 徐小菊, 范国荣. 帕洛诺司琼预防化疗所致恶心呕吐的快速卫生技术评估. 世界临床药物, 2023 , 44 (6) : 580 -586 . DOI: 10.13683/j.wph.2023.06.011
Yue YOU, Xiaoju XU, Guorong FAN. Rapid health technology assessment of palonosetron in the prevention of chemotherapy-induced nausea and vomiting[J]. World Clinical Drug, 2023 , 44 (6) : 580 -586 . DOI: 10.13683/j.wph.2023.06.011
Year 2023 volume 44 Issue 6
13
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.06.011
  • Receive Date:2022-11-24
  • Online Date:2026-11-18
  • Published:2023-06-10
Article Data
Affiliations
History
  • Received:2022-11-24
Affiliations
    Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.06.011
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT